A sampling of equids from the state of Oklahoma produced an estimate of seroprevalence of antibody to Sarcocystis neurona to be about 89.2%. This figure represents the highest currently reported regional seroprevalence of antibody to this organism. Regional differences in seroprevalence were found in the western quadrants of the state relative to the eastern quadrants of the state, with a significantly higher seroprevalence in the eastern regions. Thoroughbreds were found to exhibit a statistically significant lower seroprevalence as a breed group when compared with other breeds sampled.
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Seroprevalence of antibodies to Sarcocystis neurona in equids residing in Oklahoma
Bradford G. Bentz 1 , Katie A. Ealey, Jennifer Morrow, P. L. Claypool, Jeremiah T. Saliki Abstract. A sampling of equids from the state of Oklahoma produced an estimate of seroprevalence of antibody to Sarcocystis neurona to be about 89.2%. This figure represents the highest currently reported regional seroprevalence of antibody to this organism. Regional differences in seroprevalence were found in the western quadrants of the state relative to the eastern quadrants of the state, with a significantly higher seroprevalence in the eastern regions. Thoroughbreds were found to exhibit a statistically significant lower seroprevalence as a breed group when compared with other breeds sampled.
Equine protozoal myeloencephalitis (EPM) is a disease that affects the central nervous system of the horse. The disease and its clinical presentation have been reviewed elsewhere. 4, 7, 8 In brief, the presenting clinical signs are variable but are related to central nervous system dysfunction that occurs in relation to infection and inflammation associated with a protozoal organism. Despite the fact that more than 1 type of protozoan has been associated with this disease, to date the most commonly associated protozoan is Sarcocystis neurona.
Seroprevalence studies have been conducted in northern Colorado, Michigan, Ohio, Oregon, and southeastern Pennsylvania to estimate the rate of exposure of horses to S. neurona, relative to the geography of the USA. These reports have estimated overall statewide seroprevalences of 33.6%, 60%, 53.6%, 45%, and 45.3%, respectively. 2, 3, 10, 12, 13 To date, there are no published data pertaining to the seroprevalence of antibodies against S. neurona in the south-central USA.
The purpose of this investigation was to estimate the seroprevalence of this antibody in the state of Oklahoma and to evaluate for relationships between seroprevalence and geographic location within the state and signalment of the test animals.
Immunoblot analysis for anti-S. neurona antibody was performed as previously described 6 analysis by a commercial laboratory that offers immunoblot analysis for both serum and cerebrospinal fluid. a Data were recorded for each sample regarding county from which the sample was submitted, age of the horse, breed of the horse, and sex of the horse. Reactivity for proteins with relative mobilities of 14.5, 13, and 7 kD were considered positive indicators of exposure to S. neurona. Weak positive and low positive reactivities were regarded as positive because any reactivity indicates exposure to the organism. The overall seroprevalence was estimated from the results of the immunoblot analysis of 798 samples submitted. Statistical analysis was performed to determine the relationship of seroprevalence to age, breed, sex, and geographic quadrant within the state of Oklahoma. A computerized statistics program was used for all statistical calculations. b On the basis of 798 samples of equids and a 95% confidence interval, the overall statewide seroprevalence is estimated to be 89.2% Ϯ 2.1% (712/798). There were 792 samples for which geographic data regarding the origin of the sample were available. The state was divided into quadrants on the basis of average rainfall and temperature. The western quadrants of the state experience less rainfall relative to the eastern quadrants, and the southern quadrants are warmer on average than the northern quadrants. From the data obtained, the seroprevalence was determined for each quadrant of the state using a 95% confidence interval. The northwest quadrant exhibited a 70.7% Ϯ 6.9% seroprevalence on the basis of 167 samples. The seroprevalence in the southwest quadrant was 83.3% Ϯ 9.4% from 60 samples. The seroprevalence in the northeast quadrant was found to be 96.3% Ϯ 1.7% on the basis of 457 samples. The seroprevalence in the southeast quadrant was 95.4% Ϯ 4.0% from 108 samples ( Fig. 1) .
A chi-square test and a 0.05 level of significance were used to evaluate for statistically significant regional differences within the state. There were statistically significant differences in the seroprevalence es- 58) , 5-year-olds (n ϭ 51), and older than 5 years (n ϭ 422). There was a statistically significant difference in the seroprevalence of all the age classes from that of the yearling class (Fig. 2) .
Two-year-olds showed no difference in seroprevalence in comparison with that of all classes other than the yearlings (P ϭ 0.26, 0.40, 0.77, and 0.95 respectively). The 3-year-old class seroprevalence was statistically different from that of the 4-year-old class but not from that of the 5-year-old and older than 5 years classes (P ϭ 0.38 and 0.52, respectively). The 4-year-old class exhibited no statistically significant difference with the 5-year-old class and the older than 5 years class (P ϭ 0.25 and 0.29, respectively). There was no statistically significant difference between the 5-year-old class seroprevalence and that of the class of horses that were older than 5 years (P ϭ 0.72). Overall, there appeared to be a trend toward a higher seroprevalence with age ( Fig. 2 ). This finding supports those of the other seroprevalence investigations already published. 2, 3, 10, 12, 13 Because of the effect of low numbers on the validity of the statistics, any breed that was represented in the sample population sample by fewer than 20 was cat-egorized as ''other'' for breed seroprevalence comparisons. A summary of the breed distribution of the test population is shown in Table 1 . Breed analysis indicated that Thoroughbred horses exhibited a statistically significant lower seroprevalence to that exhibited by all other breeds. Comparison of all other breeds indicated no statistically significant differences in seroprevalences (the lowest calculated P value was 0.09). There was no statistical difference in the relationship of seroprevalence and sex (P ϭ 0.130).
Consultation with the producer of the EPM vaccine c indicated that about 1,000 doses of the vaccine had been sold in the state of Oklahoma at the time of completion of the study. The impact of this vaccine on seroprevalence was believed to be minimal because the estimated number of horses in the state of Oklahoma is 315,000 in 2001 5 and because it is possible, if not likely, that all the vaccine sold had not yet been administered. Even if one assumes that all the vaccine had been administered, the impact on the seroprevalence of a population of 315,000 horses would only slightly change the seroprevalence and may not have any significant effect on the estimate generated from our sample population.
In a recent investigation, a modification of the immunoblot analysis was reported to boost sensitivity and specificity of the immunoblot analysis to nearly 100%. 11 The improvement of the immunoblot analysis was based on the elimination of any cross-reactivity that may occur with Sarcocystis cruzi by preincubation of the blots in pooled bovine serum. Despite this report, the present investigation has used the original immunoblot analysis as outlined by Granstrom et al. 6 The immunoblot used for this investigation is justified and is believed to provide an accurate estimate of the seroprevalences reported for the state of Oklahoma. Two recent review articles have addressed the putative improvement of the sensitivity and specificity offered by the modified immunoblot test. 4, 8 In these articles, there are a number of arguments presented that indicate that there is little justification of the claim of enhanced sensitivity and specificity provided by the modified immunoblot analysis. The standard immunoblot test, developed in 1991, was developed to exclude cross-reactivity with S. cruzi, Sarcocystis muris, and Sarcocystis fayeri antisera. 4, 8 Furthermore, S. cruzi, the organism that is the focus of the technique of preincubation for elimination of cross-reactivity by the modified test, does not appear to infect the horse, and horses are not known to produce antibody to this parasite. 4, 8 Sarcocystis falcatula is closely related to S. neurona, but sporocysts of this parasite do not produce a detectable antibody response to this parasite when they are orally administered to horses. 4, 8 Sarcosystis cruzi and S. fayeri share many common antigens, but horses with sarcocystosis (presumed to be S. fayeri) routinely test seronegative when evaluated using the standard immunoblot test for S. neurona. 4, 8 The original immunoblot test was evaluated in 1995 using sera from 300 wild horses indigenous to the state of Utah, where there exist canids but no opossums. In these sera, antisarcocystis antibody was detected frequently, but only 1 sample tested positive for antibody directed against S. neurona. 4, 8 The negative control sera used to validate the modified immunoblot test were obtained from India and Germany. It is possible that these sera could have had antibody to equine Sarcocystis spp. unique to those areas. The modified immunoblot test utilizes 30-and 16-kD protein reactivity as indicators of positive reactivity for antibody to S. neurona. However, it has been argued that these proteins are not S. neurona-specific and are reported to routinely cross-react with sera from horses infected with S. fayeri. 4, 8 Furthermore, 95% of the negative control sera used to validate the modified immunoblot reacted to the 30-kD protein and 81% of the sera reacted to the 16-kD protein when the blocking technique was not used. After preincubation with bovine serum as the blocking agent, 19% of the samples still reacted to the 30-kD protein and 11% still reacted to the 16-kD protein. 4, 8 Before blocking with bovine serum, 16% to 67% of these negative control sera reacted with at least 1 of the 4 proteins tentatively identified by the investigators as those used to interpret the standard immunoblot test. When the control blots using bovine antiserum only were developed using antibovine IgG, the 30-and 16-kD proteins and those tentatively identified as S. neurona-specific all failed to exhibit any reactivity. 4 Finally, in an unpublished double-blinded study, serum samples were split between 2 laboratories. One laboratory used the standard immunoblot test, and the other used the modified immunoblot analysis. The results failed to substantiate the existence of any significant difference in sensitivity and specificity between these 2 immunoblot techniques. 8 The present sample size may not have been large enough to draw specific conclusions on the overall accuracy of seroprevalence of antibody to S neurona within this state. Furthermore, our sample collection may have been affected by the proximity of the sampled horses to the laboratory from which the samples were obtained. Using the banked sera from this laboratory, it is more likely to sample horses that receive more regular care and use and horses that travel more frequently within the state. The number of horses that are infrequently shipped and/or shown affects the likelihood of their having had blood drawn for serologic testing (such as a Coggins test). This population of horses could be significantly large in this state and therefore could skew the results of this sampling method.
In 1996, the American Horse Council (AHC) estimated the overall population of horses in Oklahoma to be 278,000. 1 An annual growth rate of 2.7% was also postulated when the 1996 estimate was compared with an estimate for 1986. Presuming these data to be relatively accurate, the current population of horses in Oklahoma would be about 326,185. However, this rate of growth could be greater than that which actually occurred. Indeed, an estimate of the horse population of Oklahoma in 1998 by the National Agricultural Statistics Service indicated there were about 170,000 horses at that time, representing a significant reduction in the population relative to the AHC figure from 2 years earlier. 9 Another estimate of horse population indicated there were approximately 315,000 horses in Oklahoma in 2001. 5 Given these numbers, our population sampling may represent anywhere from 0.24% to 0.47% of the entire equine population of Oklahoma. The distribution of the Oklahoma horse population is undefined. However, this investigation assumes that the demographics of the sampled population paralleled the overall distribution of the population within the state. The estimated seroprevalence from the sample population of horses in Oklahoma indicates a high rate of exposure to S. neurona. To date, there are no other statewide studies that have indicated a seroprevalence of this magnitude. Despite this finding, anecdotally, there does not appear to be a greater number of cases of EPM in the state of Oklahoma relative to that reported elsewhere in the USA.
